Advance Contract Award Notice (ACAN)
Title: Expert membership for the Non-Insured Health Benefits (NIHB) Drugs and Therapeutics Advisory Committee (DTAC)
Solicitation Number: 1000197059
1. The Purpose and Explanation of an ACAN
An Advance Contract Award Notice (ACAN) allows The Department of Indigenous Services Canada to post a notice for no less than fifteen (15) calendar days, indicating to the supplier community that a goods, services or construction contract will be awarded to a pre-identified contractor. If no other supplier submits, on or before the closing date, a Statement of Capabilities that meets the minimum requirements identified in the ACAN, the Contracting Authority may then proceed to award a contract to the pre-identified contractor.
2. Rights of Suppliers
Suppliers who consider themselves fully qualified and available to provide the services or goods described in this ACAN may submit a Statement of Capabilities demonstrating how they meet the advertised requirement. This Statement of Capabilities must be provided via e-mail only to the contact person identified in Section 12 of the Notice on or before the closing date and time of the Notice. If the Bidder can clearly demonstrate they possess the required capabilities, the requirement will be opened to electronic or traditional bidding processes.
3. Proposed Contractor
Ann Duggan, 2836 Grandeur Avenue, Ottawa, On, K2B 6Y9
Derek Jorgenson, 935 Budz Green, Saskatoon, SK, S7N 4M9
Francois Lavoie, 14 Lourmarin, Blainville, QC, J7B 1Y3
Michael Perley, 1 Maliseet Drive, Woodstock FN, NB, E7M 4J5
Omar Rahaman, 154 Meadowlark Health, Edmonton, AB, T5R 5W9
Howard Zacharias, P.O. Box 2470, Morden, MB, R6M 1C2
Marlyn Cook, Box 190, St. Laurent, MB, R0C 2S0
Tara Gomes, 79 Hook Avenue, Toronto, ON, M6P 1T3
Kunal Minhas, 116 Marine Drive, Winnipeg, MB, R2N 0E1
Peter Zed, 5422 Crescent Drive, Delta, BC, V4K 2C9
4. Definition of Requirements or Expected Results
As part of DTAC, Committee members will be required to be active participants in discussions leading to the provision of recommendations to the NIHB Program which lead to a cost-effective drug formulary and improved prescribing, dispensing and use of drugs among First Nations and Inuit clients. Recommendations may be required regarding the following:
Clarification of Common Drug Review (CDR) and/or pan-Canadian Oncology Drug Review (pCODR) recommendations when required as well as offer additional expert review due to the specific needs of First Nations and Inuit clients.
Review of drugs or drug classes not reviewed by CDR or not under the mandate of the CDR Process. In this case, the Committee can provide one of the following recommendations:
List (open benefit)
List with Criteria
Do Not List (Exception – requests reviewed case by case)
Exclusion (Drug not covered under any circumstances)
Review of individual requests by the NIHB Program for a drug or drug class review of existing NIHB DBL drug listing(s).
Maintenance and improvement of the centralized NIHB drug utilization evaluation (DUE) Program with recommendations and interventions being implemented at the national and regional level.
Establishment and review of criteria for retrospective national DUE and set out the terms for a specified number of retrospective DUE analyses.
Recommendation and monitoring of approved DUE projects, as required.
Recommendation of national policies, systems and procedures for retrospective DUE activities.
h. Provision of specific recommendations based on the DUE analyses reviewed by the Committee.
5. Minimum Requirements
Any interested supplier must demonstrate by way of a Statement of Capabilities that it meets the following minimum requirements:
To be considered as a member of the DTAC the candidate must hold a qualification and licensure in Canada as a physician, pharmacist, registered nurse or other professional with expertise in one or more areas such as, but not limited to:
a. drug use evaluation/utilization
b. critical appraisal
c. clinical epidemiology
d. medical or pharmacy quality assurance
e. aboriginal health issues
f. health systems research
g. medical or pharmacy education with First Nations expertise
h. pharmacoeconomics
i. general practice
j. internal medicine
k. hospital or community pharmacy
l. ethics
m. geriatrics
n. pediatrics
o. drug addiction treatment or prevention
6. Reason for Non-Competitive Award
Part 1, Section 6 (c) The nature of the work is such that it would not be in the public interest to solicit bids.
7. Applicable trade Agreements and Justification for Limited Tendering or the Procurement Strategy for Aboriginal Business
This procurement is subject to the following:
- Canadian Free Trade Agreement, (CFTA), Article 508
- North American Free Trade Agreement (NAFTA), Article 1011
- World Trade Organization (WTO), Article VIII
8. Ownership of Intellectual Property
If any, the Intellectual Property will be owned by the contractor.
9. Period of the Proposed Contract
The services of the Contractor will be required for a period of 2 years, with 3 additional option years, commencing upon awarding of the sole-sourced contract. The expected completion date of this contract is March 31, 2020.
10. Estimated Value of the Proposed Contract
The total estimated value of all ten (10) resulting contracts including all option periods shall not exceed $798,462.50 including travel and living expenses (if applicable), and all applicable taxes.
11. Closing Date and Time
The Closing Date and Time for accepting Statements of Capabilities is March 13, 2018, 2 p.m. EST.
12. Contact Person
All enquiries must be addressed by e-mail to:
Name: Shari Rochon
E-Mail: s••••••••@••••••.ca
